Learn How to Analyze Your Market and Trading Plan
Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.
Download Your FREE Options Trading Strategy Guide today!
pixel

NVCR Insider Trading (NovoCure)

Insider Ownership Percentage: 5.07%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $69,113,779.20

NovoCure Insider Trading History Chart

NovoCure Share Price & Price History

$132.09
▼ -0.43 (-0.32%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
Buying Tesla Stock? Wait Until You See This...
With most investors focused on big tech, a frenzy is quietly erupting in one tiny sector, with gains like 500% in two months and 104% in a single day.
Click Here...
pixel

NovoCure Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/1/2021William F DoyleChairmanSell7,928$134.12$1,063,303.36658,321  
2/28/2021Wilhelmus Cm GroenhuysenCOOSell3,670$72.22$265,047.40150,014  
1/15/2021Todd Christopher LongsworthGeneral CounselSell63,814$172.48$11,006,638.72123,474  
12/21/2020Ely BenaimInsiderSell2,484$156.71$389,267.6431,189  
12/18/2020Asaf DanzigerCEOSell207,910$157.39$32,722,954.90301,587  
12/18/2020Jeryl L HillemanDirectorSell2,500$166.40$416,000.003,400  
11/2/2020Ashley CordovaCFOSell230$117.41$27,004.3026,212  
9/25/2020Uri WeinbergInsiderSell15,250$103.35$1,576,087.5036,347  
9/17/2020Wilhelmus Cm GroenhuysenCOOSell12,500$108.60$1,357,500.00144,540  
9/15/2020Wilhelmus Cm GroenhuysenCOOSell50,868$103.27$5,253,138.36155,107  
9/14/2020Gabriel LeungDirectorSell10,000$95.00$950,000.0082,045  
9/10/2020Gabriel LeungDirectorSell10,000$90.00$900,000.0081,159  
9/9/2020Pritesh ShahInsiderSell28,321$85.41$2,418,896.6171,165  
9/2/2020Gabriel LeungDirectorSell100$85.00$8,500.0072,145  
8/25/2020Gabriel LeungDirectorSell7,112$80.13$569,884.5679,157  
7/31/2020Ely BenaimInsiderSell341$76.39$26,048.99  
7/31/2020William F DoyleChairmanSell896$76.39$68,445.44649,062  
7/30/2020Gabriel LeungDirectorSell7,112$75.00$533,400.0079,157  
7/22/2020Gabriel LeungDirectorSell9,500$67.03$636,785.0072,545  
7/22/2020Michael J AmbrogiCOOSell42,972$67.02$2,879,983.44221,167  
5/11/2020Ely BenaimInsiderSell1,611$63.73$102,669.0316,822  
5/11/2020William F DoyleChairmanSell31,332$63.73$1,996,788.36649,958  
5/6/2020William F DoyleChairmanSell29,881$64.27$1,920,451.87628,047  
5/4/2020Pritesh ShahInsiderSell1,184$60.08$71,134.72103,026  
4/14/2020Michael J AmbrogiCOOSell27,519$71.00$1,953,849.00243,622  
2/25/2020Michael J AmbrogiCOOSell11,647$81.16$945,270.52216,873  
2/25/2020Pritesh ShahInsiderSell5,067$81.16$411,237.7275,653  
2/25/2020Todd Christopher LongsworthGeneral CounselSell8,482$81.16$688,399.1275,601  
2/25/2020Wilhelmus Cm GroenhuysenCFOSell18,908$81.16$1,534,573.28130,676  
1/22/2020Wilhelmus Cm GroenhuysenCFOSell2,915$98.14$286,078.1088,858  
1/17/2020William F DoyleChairmanSell133,777$95.00$12,708,815.00509,465  
12/2/2019Charles G Phillips IIIDirectorSell6,145$88.11$541,435.953,359  
11/25/2019Asaf DanzigerCEOSell103,000$95.00$9,785,000.00237,601  
11/25/2019Gabriel LeungDirectorSell20,000$95.00$1,900,000.0089,504  
11/25/2019William F DoyleChairmanSell16,223$96.04$1,558,056.92643,242  
11/20/2019Gabriel LeungDirectorSell20,000$90.00$1,800,000.0089,504  
11/20/2019William F DoyleChairmanSell150,000$90.36$13,554,000.00660,165  
11/18/2019Gabriel LeungDirectorSell20,000$90.68$1,813,600.00
11/18/2019Wilhelmus Cm GroenhuysenCFOSell25,832$90.68$2,342,445.76
11/14/2019Wilhelmus Cm GroenhuysenCFOSell27,576$81.87$2,257,647.1297,179  
11/11/2019Gabriel LeungDirectorSell5,000$79.57$397,850.0074,504  
11/11/2019Wilhelmus Cm GroenhuysenCFOSell8,600$80.13$689,118.0089,079  
11/11/2019William F DoyleChairmanSell29,782$80.11$2,385,836.02822,683  
11/4/2019Michael J AmbrogiCOOSell80,819$79.00$6,384,701.00195,743  
10/10/2019Gabriel LeungDirectorSell5,000$72.28$361,400.0074,504  
9/24/2019Wilhelmus Cm GroenhuysenCFOSell7,992$80.63$644,394.9689,179  
9/16/2019Wilhelmus Cm GroenhuysenCFOSell25,000$78.93$1,973,250.00112,179  
9/12/2019Wilhelmus Cm GroenhuysenCFOSell25,000$79.57$1,989,250.00112,179  
9/10/2019Gabriel LeungDirectorSell5,000$76.63$383,150.0074,504  
9/9/2019Wilhelmus Cm GroenhuysenCFOSell25,000$80.83$2,020,750.00112,179  
9/3/2019Todd Christopher LongsworthGeneral CounselSell158,440$87.87$13,922,122.80113,420  
8/30/2019Charles G Phillips IIIDirectorSell22,000$91.14$2,005,080.0031,504  
8/29/2019Asaf DanzigerCEOSell124,181$91.13$11,316,614.53200,869  
8/12/2019Gabriel LeungDirectorSell5,000$86.45$432,250.0074,504  
8/1/2019Pritesh ShahInsiderSell7,020$83.00$582,660.0082,091  
7/26/2019Pritesh ShahInsiderSell12,500$77.94$974,250.0089,476  
7/18/2019Pritesh ShahInsiderSell7,500$70.00$525,000.0084,476  
7/10/2019Gabriel LeungDirectorSell5,000$64.83$324,150.0074,504  
6/28/2019Asaf DanzigerCEOSell187,500$62.15$11,653,125.00445,811  
6/27/2019Pritesh ShahInsiderSell11,175$60.30$673,852.5065,037  
6/19/2019Gabriel LeungDirectorSell25,000$60.02$1,500,500.0094,504  
6/19/2019Michael J AmbrogiCOOSell110,868$60.00$6,652,080.00296,542  
6/19/2019Pritesh ShahInsiderSell12,500$60.00$750,000.0088,712  
6/18/2019Asaf DanzigerCEOSell190,338$59.37$11,300,367.06448,649  
6/12/2019Asaf DanzigerCEOSell30,436$55.39$1,685,850.04275,146  
6/10/2019Gabriel LeungDirectorSell5,000$55.05$275,250.0074,504  
6/10/2019Pritesh ShahInsiderSell1,130$55.05$62,206.5076,272  
6/6/2019Michael J AmbrogiCOOSell5,999$54.79$328,685.21191,673  
6/4/2019Michael J AmbrogiCOOSell35,000$52.62$1,841,700.00203,174  
5/29/2019Charles G Phillips IIIDirectorSell95,100$52.17$4,961,367.0059,504  
5/29/2019William F DoyleInsiderSell1,900$53.10$100,890.00894,563  
5/10/2019Gabriel LeungDirectorSell5,000$49.79$248,950.00  
5/8/2019William F DoyleInsiderSell64,316$47.60$3,061,441.60842,605  
5/6/2019William F DoyleInsiderSell29,038$48.07$1,395,856.66815,935  
5/3/2019William F. DoyleChairmanSell29,966$45.21$1,354,762.86  
5/2/2019Pritesh ShahInsiderSell1,204$43.80$52,735.20  
4/10/2019Gabriel LeungDirectorSell5,000$45.95$229,750.0065,000  
4/1/2019Michael J AmbrogiCOOSell34,375$47.39$1,629,031.25207,549  
3/11/2019Gabriel LeungDirectorSell5,000$48.31$241,550.0065,000  
3/5/2019Wilhelmus Cm GroenhuysenCFOSell90,000$53.94$4,854,600.0085,030  
3/4/2019Asaf DanzigerCEOSell16,268$55.89$909,218.52250,025  
3/1/2019Gabriel LeungDirectorSell25,000$55.01$1,375,250.00  
2/28/2019Asaf DanzigerCEOSell903$54.40$49,123.20233,757  
2/28/2019Michael J AmbrogiCOOSell2,397$53.68$128,670.96171,702  
2/28/2019Pritesh ShahInsiderSell1,558$53.68$83,633.4426,797  
2/28/2019Todd Christopher LongsworthGeneral CounselSell2,368$53.68$127,114.2439,203  
2/28/2019Wilhelmus Cm GroenhuysenCFOSell3,288$53.68$176,499.8469,552  
2/28/2019William F DoyleChairmanSell3,097$53.68$166,246.96921,403  
2/13/2019Asaf DanzigerCEOSell50,000$51.46$2,573,000.00  
2/11/2019Gabriel LeungDirectorSell5,000$49.59$247,950.0065,000  
2/4/2019Michael J AmbrogiCOOSell58,500$49.21$2,878,785.00184,058  
2/1/2019Michael J AmbrogiCOOSell37,500$49.03$1,838,625.00184,058  
1/25/2019Gabriel LeungDirectorSell20,000$50.00$1,000,000.0080,000  
1/25/2019Todd Christopher LongsworthGeneral CounselSell26,874$49.03$1,317,632.2236,305  
1/25/2019Wilhelmus Cm GroenhuysenCFOSell35,000$49.20$1,722,000.0072,149  
1/23/2019Asaf DanzigerCEOSell88,695$47.48$4,211,238.60259,859  
1/23/2019Wilhelmus Cm GroenhuysenCFOSell35,000$47.35$1,657,250.0072,149  
1/18/2019Wilhelmus Cm GroenhuysenCFOSell30,000$45.90$1,377,000.0067,149  
1/17/2019Asaf DanzigerCEOSell100,000$45.26$4,526,000.00271,164  
1/16/2019Gabriel LeungDirectorSell20,000$45.00$900,000.0080,000  
1/16/2019Pritesh ShahInsiderSell25,000$45.00$1,125,000.0029,587  
1/16/2019Todd Christopher LongsworthGeneral CounselSell15,000$45.15$677,250.0036,305  
1/15/2019Asaf DanzigerCEOSell200,000$43.51$8,702,000.00271,164  
1/15/2019Wilhelmus Cm GroenhuysenCFOSell30,000$44.20$1,326,000.0067,149  
1/11/2019Pritesh ShahInsiderSell26,251$42.00$1,102,542.0025,838  
1/11/2019Wilhelmus Cm GroenhuysenCFOSell30,000$42.35$1,270,500.0037,149  
1/9/2019Gabriel LeungDirectorSell20,000$40.00$800,000.0080,000  
1/9/2019Michael J AmbrogiCOOSell100,000$40.00$4,000,000.00221,558  
1/9/2019Pritesh ShahInsiderSell8,988$40.00$359,520.0026,075  
1/9/2019Todd Christopher LongsworthGeneral CounselSell15,000$40.15$602,250.0036,305  
12/12/2018Pritesh ShahInsiderSell38,781$36.00$1,396,116.0039,619  
12/10/2018Gabriel LeungDirectorSell5,000$33.49$167,450.0065,000  
8/27/2018Wilhelmus Cm GroenhuysenCFOSell35,547$40.01$1,422,235.4747,397  
8/27/2018Yoram PaltiInsiderSell25,666$40.03$1,027,409.98  
8/24/2018Wilhelmus Cm GroenhuysenCFOSell25,574$40.00$1,022,960.0047,397  
8/24/2018Yoram PaltiCTOSell12,216$40.00$488,640.00  
8/22/2018Wilhelmus Cm GroenhuysenCFOSell31,179$37.67$1,174,512.9372,671  
8/14/2018Wilhelmus Cm GroenhuysenCFOSell4,368$37.62$164,324.16108,118  
8/1/2018Wilhelmus Cm GroenhuysenCFOSell1,241$35.01$43,447.41115,644  
7/27/2018Wilhelmus Cm GroenhuysenCFOSell62,727$35.08$2,200,463.16175,602  
7/2/2018Michael J AmbrogiCOOSell57,390$31.48$1,806,637.20174,383  
6/27/2018Asaf DanzigerCEOSell70,364$32.09$2,257,980.7669,318  
6/20/2018Asaf DanzigerCEOSell8,308$32.04$266,188.32147,990  
6/18/2018Asaf DanzigerCEOSell22,289$32.00$713,248.00147,990  
6/14/2018Asaf DanzigerCEOSell11,920$32.00$381,440.00171,100  
6/14/2018Yoram PaltiInsiderSell30,000$31.64$949,200.00  
6/4/2018Asaf DanzigerCEOSell227,304$29.09$6,612,273.36260,246  
6/4/2018Eilon D KirsonInsiderSell346,161$28.90$10,004,052.90258,363  
5/25/2018Charles G Phillips IIIDirectorSell50,000$30.30$1,515,000.0050,000  
5/16/2018Gabriel LeungDirectorSell80,000$28.83$2,306,400.00  
5/14/2018Wilhelmus Cm GroenhuysenCFOSell30,470$30.04$915,318.80201,898  
5/11/2018Wilhelmus Cm GroenhuysenCFOSell9,393$30.01$281,883.93201,898  
5/1/2018Michael J AmbrogiCOOSell60,000$27.40$1,644,000.00  
5/1/2018Wilhelmus Cm GroenhuysenCFOSell30,470$27.58$840,362.60  
4/26/2018Michael J AmbrogiCOOSell20,000$26.01$520,200.00166,558  
4/26/2018Yoram PaltiInsiderSell20,966$26.09$547,002.94  
4/24/2018Yoram PaltiInsiderSell35,600$25.06$892,136.00  
4/20/2018Yoram PaltiCTOSell19,362$25.06$485,211.72  
4/18/2018Michael J AmbrogiCOOSell40,000$23.03$921,200.00166,558  
4/18/2018Yoram PaltiInsiderSell44,072$23.65$1,042,302.80116,451  
See Full Table

SEC Filings (Institutional Ownership Changes) for NovoCure (NASDAQ:NVCR)

71.09% of NovoCure stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

NovoCure Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
4/9/2021State of Alaska Department of Revenue533$70K0.0%N/A0.001%
4/9/2021Scout Investments Inc.77,226$10.21M0.2%-24.2%0.075%
4/7/2021Hodges Capital Management Inc.25,000$3.31M0.5%+22.0%0.024%
3/9/2021tru Independence LLC253$43.26M0.1%N/A0.000%
3/9/2021Amundi Pioneer Asset Management Inc.31,228$5.40M0.0%N/A0.030%
3/8/2021Teachers Retirement System of The State of Kentucky92,809$16.06M0.2%+4.6%0.091%
3/8/2021Dimensional Fund Advisors LP164,314$28.43M0.0%+4.4%0.160%
3/2/2021FormulaFolio Investments LLC5,661$0.98M0.0%N/A0.006%
3/2/2021Norges Bank856,846$148.27M0.0%N/A0.842%
3/1/2021UBS Asset Management Americas Inc.222,279$38.46M0.0%+102.3%0.218%
2/25/2021Dimensional Fund Advisors LP164,314$28.43M0.0%+4.4%0.161%
2/25/2021Hsbc Holdings PLC3,763$0.65M0.0%+36.9%0.004%
2/24/2021Sheets Smith Investment Management6,575$1.14M1.0%N/A0.006%
2/23/2021Principal Financial Group Inc.12,182$2.11M0.0%-63.6%0.012%
2/22/2021Achmea Investment Management B.V.4,453$0.77M0.0%N/A0.004%
2/19/2021Albion Financial Group UT1,000$0.17M0.0%N/A0.001%
2/18/2021Truist Financial Corp5,649$0.98M0.0%+201.8%0.006%
2/17/2021Voloridge Investment Management LLC176,883$30.61M0.3%+117.6%0.174%
2/17/2021Castleark Management LLC13,245$2.29M0.1%N/A0.013%
2/17/2021Cetera Advisor Networks LLC1,308$0.23M0.0%N/A0.001%
2/16/2021Zacks Investment Management5,700$0.99M0.0%-61.6%0.006%
2/16/2021Squarepoint Ops LLC23,811$4.12M0.0%+121.0%0.023%
2/16/2021Morgan Stanley1,350,654$233.72M0.0%+2.1%1.327%
2/16/2021Tudor Investment Corp Et Al15,472$2.68M0.1%N/A0.015%
2/16/2021Nuveen Asset Management LLC488,057$84.45M0.0%+37.5%0.479%
2/16/2021Colony Group LLC98,370$17.02M0.4%-3.0%0.097%
2/16/2021Guggenheim Capital LLC22,237$3.85M0.0%-8.9%0.022%
2/16/2021Price T Rowe Associates Inc. MD1,238,204$214.26M0.0%+1.9%1.216%
2/16/2021Kingsview Wealth Management LLC13,392$2.32M0.2%+5.1%0.013%
2/16/2021Amundi Pioneer Asset Management Inc.31,228$5.40M0.0%N/A0.031%
2/16/2021Jefferies Group LLC13,600$2.35M0.0%N/A0.013%
2/16/2021Virginia Retirement Systems ET AL10,100$1.75M0.0%-42.9%0.010%
2/16/2021ETF Managers Group LLC68,417$11.91M0.3%-30.6%0.067%
2/16/2021Schroder Investment Management Group56,898$9.85M0.0%N/A0.056%
2/16/2021Engineers Gate Manager LP12,837$2.22M0.1%-56.9%0.013%
2/16/2021Janus Henderson Group PLC5,614$0.97M0.0%N/A0.006%
2/16/2021ExodusPoint Capital Management LP29,054$5.03M0.0%-49.4%0.029%
2/16/2021Capital International Ltd.59,618$10.32M0.6%+1.4%0.059%
2/16/2021Charles Schwab Investment Management Inc.575,528$99.59M0.0%-1.6%0.565%
2/13/2021Essex Investment Management Co. LLC21,299$3.69M0.5%-33.1%0.021%
2/13/2021American International Group Inc.2,530$0.44M0.0%-2.7%0.002%
2/12/2021Stifel Financial Corp10,047$1.74M0.0%+14.0%0.010%
2/12/2021Allstate Corp1,195$0.21M0.0%N/A0.001%
2/12/2021CWM Advisors LLC1,995$0.35M0.1%N/A0.002%
2/12/2021Federated Hermes Inc.95,622$16.55M0.0%+45.2%0.094%
2/12/2021Raymond James Financial Services Advisors Inc.25,461$4.41M0.0%-0.4%0.025%
2/12/2021LPL Financial LLC24,649$4.27M0.0%-3.6%0.024%
2/12/2021The Manufacturers Life Insurance Company15,099$2.61M0.0%+3.3%0.015%
2/12/2021Advisory Research Inc.25,609$4.43M0.3%-39.0%0.025%
2/12/2021Nomura Asset Management Co. Ltd.14,980$2.59M0.0%N/A0.015%
2/12/2021Nordea Investment Management AB3,914$0.68M0.0%N/A0.004%
2/12/2021Regent Peak Wealth Advisors LLC335$58K0.0%N/A0.000%
2/12/2021M&T Bank Corp6,024$1.04M0.0%-2.0%0.006%
2/12/2021Regal Investment Advisors LLC1,160$0.20M0.0%N/A0.001%
2/11/2021Lazard Asset Management LLC970$0.17M0.0%-47.5%0.001%
2/11/2021Wetherby Asset Management Inc.2,646$0.46M0.0%+22.6%0.003%
2/11/2021Northern Trust Corp564,348$97.66M0.0%+22.3%0.554%
2/11/2021Baird Financial Group Inc.6,899$1.19M0.0%-11.4%0.007%
2/11/2021Citigroup Inc.137,385$23.77M0.0%+116.2%0.135%
2/11/2021Handelsbanken Fonder AB15,923$2.76M0.0%N/A0.016%
2/11/2021Teacher Retirement System of Texas7,989$1.38M0.0%+64.8%0.008%
2/11/2021Steward Partners Investment Advisory LLC1,264$0.22M0.0%+532.0%0.001%
2/11/2021Phoenix Holdings Ltd.126,523$21.94M0.6%-36.1%0.124%
2/11/2021Westpac Banking Corp6,997$1.21M0.0%N/A0.007%
2/11/2021Oppenheimer Asset Management Inc.5,363$0.93M0.0%-6.3%0.005%
2/11/2021Oppenheimer & Co. Inc.1,331$0.23M0.0%N/A0.001%
2/11/2021Xponance Inc.10,488$1.82M0.0%+0.8%0.010%
2/11/2021Nicholas Investment Partners LP135,336$23.42M1.8%-32.2%0.133%
2/10/2021Rhumbline Advisers104,484$18.08M0.0%-1.3%0.103%
2/10/2021Renaissance Technologies LLC297,970$51.56M0.1%-69.5%0.293%
2/10/2021D.A. Davidson & CO.5,231$0.91M0.0%N/A0.005%
2/10/2021QS Investors LLC8,462$1.46M0.0%+2.6%0.008%
2/10/2021Cookson Peirce & Co. Inc.174,042$30.12M2.0%+2,140.2%0.171%
2/10/2021Baillie Gifford & Co.8,261,075$1.43B0.8%+1.7%8.115%
2/10/2021Aviva PLC13,742$2.38M0.0%-37.2%0.013%
2/10/2021Panagora Asset Management Inc.13,232$2.29M0.0%+33.1%0.013%
2/10/2021KBC Group NV6,969$1.21M0.0%+800.4%0.007%
2/10/2021Korea Investment CORP28,700$4.97M0.0%N/A0.028%
2/10/2021Sterling Financial Planning Inc.150$26K0.0%N/A0.000%
2/9/2021Wells Fargo & Company MN1,141,281$197.49M0.0%+5.0%1.121%
2/9/2021Advisory Services Network LLC11,372$1.97M0.1%+953.0%0.011%
2/9/2021Nvwm LLC10,549$1.83M0.8%-7.4%0.010%
2/9/2021Fiera Capital Corp385,509$66.71M0.2%+0.7%0.379%
2/9/2021Van ECK Associates Corp18,802$3.25M0.0%-34.5%0.018%
2/9/2021Hartline Investment Corp335,191$58M8.3%-0.1%0.329%
2/9/2021Andar Capital Management HK Ltd61,000$10.56M6.9%N/A0.060%
2/9/2021Donoghue Forlines LLC4,247$0.74M0.1%N/A0.004%
2/9/2021Bank of New York Mellon Corp396,579$68.62M0.0%+19.2%0.390%
2/9/2021Illinois Municipal Retirement Fund12,144$2.10M0.1%+88.4%0.012%
2/9/2021Quantinno Capital Management LP1,693$0.29M0.2%-32.0%0.002%
2/9/2021Oregon Public Employees Retirement Fund11,100$1.92M0.0%N/A0.011%
2/9/2021Blair William & Co. IL1,575$0.27M0.0%N/A0.002%
2/9/2021Chartwell Investment Partners LLC2,963$0.51M0.0%-83.7%0.003%
2/9/2021Mitsubishi UFJ Kokusai Asset Management Co. Ltd.16,146$2.79M0.0%-30.7%0.016%
2/9/2021Landscape Capital Management L.L.C.7,134$1.23M0.2%+12.2%0.007%
2/9/2021ProShare Advisors LLC1,518$0.26M0.0%-91.4%0.001%
2/8/2021CIBC World Markets Inc.10,439$1.81M0.0%+110.5%0.010%
2/8/2021Vident Investment Advisory LLC2,542$0.44M0.0%N/A0.002%
2/8/2021Alliancebernstein L.P.56,611$9.80M0.0%+7.5%0.056%
2/8/2021State Board of Administration of Florida Retirement System133,519$23.10M0.0%+18.9%0.131%
Data available starting January 2016

See Full Table
NovoCure logo
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. The company markets Optune and Optune Lua, a Tumor Treating Fields delivery system for use as a monotherapy treatment for adult patients with glioblastoma. It is also developing products for brain metastases, non-small cell lung cancer, pancreatic cancer, gastric cancer, ovarian cancer, liver cancer, and mesothelioma. The company markets its products in the European Union, Japan, and internationally. It has a clinical trial collaboration agreement with MSD to evaluate tumor treating fields together with KEYTRUDA, an anti-PD-1 therapy; and a strategic alliance with the NYU Grossman School of Medicine's Department of Radiation Oncology that provides a framework for preclinical and clinical development projects studying Tumor Treating Fields. NovoCure Limited was founded in 2000 and is based in Saint Helier, Jersey.
Read More

Today's Range

Now: $132.09
$128.80
$132.21

50 Day Range

MA: $142.55
$124.11
$190.17

52 Week Range

Now: $132.09
$55.40
$194.75

Volume

397,876 shs

Average Volume

720,342 shs

Market Capitalization

$13.53 billion

P/E Ratio

695.25

Dividend Yield

N/A

Beta

1.29

Who are the company insiders with the largest holdings of NovoCure?

NovoCure's top insider investors include:
  1. William F Doyle (Insider)
  2. William F Doyle (Chairman)
  3. Asaf Danziger (CEO)
  4. Michael J Ambrogi (COO)
  5. Wilhelmus Cm Groenhuysen (COO)
  6. Wilhelmus Cm Groenhuysen (CFO)
  7. Todd Christopher Longsworth (General Counsel)
  8. Pritesh Shah (Insider)
  9. Gabriel Leung (Director)
  10. Charles G Phillips III (Director)
  11. Uri Weinberg (Insider)
  12. Ely Benaim (Insider)
  13. Ashley Cordova (CFO)
  14. Jeryl L Hilleman (Director)
  15. William F Doyle (Chairman)

Who are the major institutional investors of NovoCure?

NovoCure's top institutional shareholders include:
  1. Scout Investments Inc. — 0.08%
  2. Hodges Capital Management Inc. — 0.02%
  3. State of Alaska Department of Revenue — 0.00%

Which major investors are selling NovoCure stock?

In the last quarter, NVCR stock was sold by these institutional investors:
  1. Scout Investments Inc.
Within the last year, company insiders that have sold NovoCure company stock include:
  1. William F Doyle (Insider)
  2. William F Doyle (Chairman)
  3. Asaf Danziger (CEO)
  4. Michael J Ambrogi (COO)
  5. Wilhelmus Cm Groenhuysen (COO)
  6. Wilhelmus Cm Groenhuysen (CFO)
  7. Todd Christopher Longsworth (General Counsel)
  8. Pritesh Shah (Insider)
  9. Gabriel Leung (Director)
  10. Charles G Phillips III (Director)
  11. Uri Weinberg (Insider)

Which major investors are buying NovoCure stock?

In the last quarter, NVCR stock was acquired by institutional investors including:
  1. Hodges Capital Management Inc.
  2. State of Alaska Department of Revenue
Learn How to Analyze Your Market and Trading Plan
Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.
Download Your FREE Options Trading Strategy Guide today!
pixel